Bacteria were first detected in human tumors more than 100 years ago, but the characterization of the tumor microbiome has remained challenging because of its low biomass. We undertook a comprehensive analysis of the tumor microbiome, studying 1526 tumors and their adjacent normal tissues across seven cancer types, including breast, lung, ovary, pancreas, melanoma, bone, and brain tumors. We found that each tumor type has a distinct microbiome composition and that breast cancer has a particularly rich and diverse microbiome. The intratumor bacteria are mostly intracellular and are present in both cancer and immune cells. We also noted correlations between intratumor bacteria or their predicted functions with tumor types and subtypes, patien...
Given the potential relationship between head and neck squamous cell carcinoma (HNSCC) and microbial...
In recent years, there has been a greater emphasis on the impact of microbial populations inhabiting...
The gut microbiome in patients with colorectal cancer (CRC) is different than that of healthy contro...
Bacteria were first detected in human tumors more than 100 years ago, but the characterization of th...
International audienceLive-pathogenic bacteria, which were identified inside tumors hundreds year ag...
By all measures of genetic diversity or species abundance, life is primarily microbial. However, dec...
Following recent findings linking the human gut microbiota to gastrointestinal cancer and its treatm...
The study of the human microbiome in oncology is a growing and rapidly evolving field. In the past f...
The microbiome plays diverse roles in many diseases and can potentially contribute to cancer develop...
Background: Breast cancer (BC) is the most common malignancy in women, in whom it reaches 20% of the...
Microbial communities that colonize in humans are collectively described as microbiome. According to...
The crosstalk between the oral microbiome and oral cancer has yet to be characterized. This study re...
The gut microbiota has been previously linked with tumorigenesis and gastrointestinal cancer progres...
Abstract Cancer is a major cause of high morbidity and mortality worldwide. Several environmental, g...
International audienceMicrobial roles in cancer formation, diagnosis, prognosis, and treatment have ...
Given the potential relationship between head and neck squamous cell carcinoma (HNSCC) and microbial...
In recent years, there has been a greater emphasis on the impact of microbial populations inhabiting...
The gut microbiome in patients with colorectal cancer (CRC) is different than that of healthy contro...
Bacteria were first detected in human tumors more than 100 years ago, but the characterization of th...
International audienceLive-pathogenic bacteria, which were identified inside tumors hundreds year ag...
By all measures of genetic diversity or species abundance, life is primarily microbial. However, dec...
Following recent findings linking the human gut microbiota to gastrointestinal cancer and its treatm...
The study of the human microbiome in oncology is a growing and rapidly evolving field. In the past f...
The microbiome plays diverse roles in many diseases and can potentially contribute to cancer develop...
Background: Breast cancer (BC) is the most common malignancy in women, in whom it reaches 20% of the...
Microbial communities that colonize in humans are collectively described as microbiome. According to...
The crosstalk between the oral microbiome and oral cancer has yet to be characterized. This study re...
The gut microbiota has been previously linked with tumorigenesis and gastrointestinal cancer progres...
Abstract Cancer is a major cause of high morbidity and mortality worldwide. Several environmental, g...
International audienceMicrobial roles in cancer formation, diagnosis, prognosis, and treatment have ...
Given the potential relationship between head and neck squamous cell carcinoma (HNSCC) and microbial...
In recent years, there has been a greater emphasis on the impact of microbial populations inhabiting...
The gut microbiome in patients with colorectal cancer (CRC) is different than that of healthy contro...